The EGA facilitates biomedical discoveries by enabling the secure sharing of research data that matches genetic information to disease characteristics. It is strictly governed by the data access committees (DACs) associated with each study, and is highly protective of deposited information.
Continually improving secure access to these data is a key driver behind this collaboration between EMBL-EBI and the Finnish Node of ELIXIR. Researchers will apply for authorisation using their host institute credentials, streamlining the process for managing account information and adding an extra layer of accountability. The action was also supporting DACs by developing advanced electronic application tools. Endorsed by Geant3Plus, this action has become a priority model for similar projects.